DAB389IL-2 recombinant fusion toxin effect on lymphocyte- and macrophage-producing cytokine subpopulation cells in experimentally induced demyelinating disease in mice-Reference-Cited by-同舟云学术

DAB389IL-2 recombinant fusion toxin effect on lymphocyte- and macrophage-producing cytokine subpopulation cells in experimentally induced demyelinating disease in mice

Published:2017-09-20 Issue:6 Volume:39 Page:318-329
ISSN:0892-3973
Container-title:Immunopharmacology and Immunotoxicology
language:en
Short-container-title:Immunopharmacology and Immunotoxicology

Author:

Bhopale Mahendra K.¹,Hilliard Brendan²,Constantinescu Cris S.³,Phillips S. Michael⁴,Rostami Abdolmohamad⁵

Affiliation:

1. Department of Radiology, Temple University School of Medicine, Philadelphia, PA, USA;

2. Department of Medicine, Temple University School of Medicine, Philadelphia, PA, USA;

3. Division of Clinical Neurology, University of Nottingham, Nottingham, UK;

4. Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA;

5. Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA

Funder

National Institutes of Health

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/08923973.2017.1369099

Reference25 articles.

1. Current and future disease-modifying therapies in multiple sclerosis

2. Update on Disease-Modifying Treatments for Multiple Sclerosis

3. Advances in the treatment of relapsing - Remitting multiple sclerosis

4. The essential role of t cells in multiple sclerosis: A reappraisal

5. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Cell-Based Therapies in Veterinary Dermatology;Wound Healing - Recent Advances and Future Opportunities;2023-06-14

2. Potent in vitro antitumor activity of B-subunit of Shiga toxin conjugated to the diphtheria toxin against breast cancer;European Journal of Pharmacology;2021-05